معرفی
Dr. Shane Wilkinson is an education-focused Lecturer at The University of Sydney’s School of Chemistry. He holds a BSc (Honours I) from the University of Sydney (2006) and a PhD from the Australian National University (2010), where he developed enzymes for drug metabolite analysis. His research spans emerging educational technologies like augmented reality (AR) for laboratory instruction and data-driven personalized teaching. Previously, he worked on medicinal chemistry targeting neurodegenerative diseases and synthetic cannabinoid analysis, including a highly cited review on designer drugs. In 2014, he transitioned to an educational role as Senior Technical Officer in 2nd Year Laboratories, later becoming a dedicated education-focused academic. His work balances innovative pedagogical tools with hands-on research in neuropharmacology and drug testing.
Education:
- BSc (Honours I) in Chemistry, University of Sydney (2006)
- PhD in Medicinal Chemistry, Australian National University (2010)
Research focuses on leveraging technology to enhance science education while maintaining strong ties to medicinal chemistry. Key areas include AR applications for lab accessibility, pre-laboratory simulations, and digital assessment tools. He has published extensively on synthetic cannabinoids, P2X7 receptor antagonists for neuroprotection, and lab pedagogy innovations. Recent work explores pandemic-era teaching adaptations and inclusive learning strategies for students with disabilities.
Publications Trends: Recent articles emphasize educational technology (e.g., labtorials, AR tools) alongside ongoing pharmacological research. Earlier work concentrated on drug metabolite synthesis and synthetic cannabinoid pharmacology, reflecting his transition from research to education.
Awards: No awards explicitly mentioned, but notable contributions include a top-access article in the Australian Journal of Chemistry (2015) and impactful work on synthetic cannabinoid dangers.
Grants/Advising: Collaborations with Prof. Michael Kassiou on medicinal chemistry projects and leadership in developing innovative laboratory curricula. No specific grants cited, but active in educational innovation initiatives.
Laboratory contributions include designing accessible lab experiences and integrating digital tools for student engagement. Current focus is on equitable education practices and hybrid learning environments.
